The Case for a Second COVID-19 Ripple, Not Wave

0
The Case for a Second COVID-19 Ripple, Not Wave
Engin_Akyurt / Pixabay

The Case for a Second COVID-19 Ripple, Not Wave by Greg Presseau Of Perennial Capital

Play Quizzes 4

Get The Full Series in PDF

Get the entire 10-part series on Charlie Munger in PDF. Save it to your desktop, read it on your tablet, or email to your colleagues.

Q2 2020 hedge fund letters, conferences and more

While the COVID-19 vaccine is within reach, we are left wondering if the return of COVID will resemble a normal flu season, starting around mid-Nov and crescendos to the SH Jan/FH Feb.  Looking at CDC data we see seasonally the flu follows the below pattern:

[Exclusive] ExodusPoint Is In The Green YTD Led By Rates And EM/ Macro Strategies

Invest ESG Leon CoopermanThe ExodusPoint Partners International Fund returned 0.36% for May, bringing its year-to-date return to 3.31% in a year that's been particularly challenging for most hedge funds, pushing many into the red. Macroeconomic factors continued to weigh on the market, resulting in significant intra-month volatility for May, although risk assets generally ended the month flat. Macro Read More

COVID-19 vaccine

Source: CDC

What’s interesting to think about is how the flu is transmitted and how each region will have varying peaks/severity.  According to Wenger and Naumova in their paper “Seasonal Synchronization of Influenza in the United States Older Adult Population”, the spread of the flu normally migrates from west to east where the former peaks earlier than the latter as per the map below:

COVID-19 vaccine

Source: Wenger & Naumova, “Seasonal Synchronization of Influenza in the United States Older Adult Population”

A COVID-19 Ripple

Something interesting that the authors attributed to the spread of the virus between regions is air travel. Air travel is at 11% of trend through May 2020.  Using two inputs, NYC average weather per month (a proxy for seasonality) and the % of trend in airline travel we can create a basic multi-regression for flu related deaths (I couldn’t find flu infections but assume deaths are highly correlated with infections).  Assuming that air travel remains stagnant, we see a much lower rate of infections/deaths. I.e. a COVID-19 ripple, not a wave:

COVID-19 vaccine

Source: CP Capital, Bloomberg

We are hopeful that we will get a vaccine just in time before the flu season kicks off and our adherence to mask rules coupled with limited air travel/public transport use will reduce the second wave to a COVID-19 ripple.

Updated on

Jacob Wolinsky is the founder of ValueWalk.com, a popular value investing and hedge fund focused investment website. Jacob worked as an equity analyst first at a micro-cap focused private equity firm, followed by a stint at a smid cap focused research shop. Jacob lives with his wife and four kids in Passaic NJ. - Email: jacob(at)www.valuewalk.com - Twitter username: JacobWolinsky - Full Disclosure: I do not purchase any equities anymore to avoid even the appearance of a conflict of interest and because at times I may receive grey areas of insider information. I have a few existing holdings from years ago, but I have sold off most of the equities and now only purchase mutual funds and some ETFs. I also own a few grams of Gold and Silver
Previous article 100 Public Pharma and CMOs took PPP COVID-19 small business loans
Next article Gold – Bitcoin Correlation Reaches Multi-Year Highs

No posts to display